Hims vs Meto
Hims and Meto sell different medications; this is what separates them.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Hims
Best for: knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC
Visit Hims →
If you are choosing between Hims and Meto, price alone will not settle it. Hims leads our six-part score, 6.8 to 4.1. One of the two has an FDA warning letter on record, covered below.
Hims vs Meto price
Hims publishes $199 a month. Meto does not post a GLP-1 price we can quote, so you would only learn its cost after an intake.
Medications and formats
Hims lists semaglutide and tirzepatide; Meto does not name its drug.
On format, Hims prices compounded injections and brand-name pens, while Meto posts no priced format.
If you want the FDA-approved brand rather than a compounded version, Hims is the only one of the two with a brand-name price.
Where each one treats patients
Hims lists 50 states, and Meto says it treats patients nationwide but does not list states.
Enter your state early in either sign-up flow: a nationwide claim is not a promise for every drug in every state.
Pricing
Hims
Brand Zepbound from $299/mo medication-only; requires Hims Weight Loss Membership ($149/mo)
Meto
Pricing not publicly listed.
What each price covers
Both prices cover the medication itself.
Meto's price also covers the clinician visit, lab work and coaching, which Hims does not claim.
Hims is silent on shipping and lab work.
Meto is silent on shipping.
Hims
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Meto
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
In the price
Coaching
In the price
Where each one scores higher
Overall, Hims scores 6.8 and Meto 4.1 out of 10.
Hims is stronger on effectiveness (10.0 vs 5.0), user experience (8.0 vs 3.0), trust & safety (7.0 vs 4.0) and accessibility (10.0 vs 5.0).
Meto is stronger on support (5.0 vs 3.0).
Value is within half a point.
Hims
6.8/10
Meto
4.1/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Hims a warning letter dated September 9, 2025 (letter 716567), and it is still open.
Meto has no FDA warning letter on record with us.
Features & Coverage
| Feature | Hims | Meto |
|---|---|---|
| Starting Price | $199/mo | Not published |
| Features | 2 features | ✓8 features |
| States Available | 50 | Not disclosed |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | ✓None |
About Hims
Hims is a major men's telehealth brand. Its weight loss offering is compounded semaglutide on a 6-month plan.
Read our full Hims review →About Meto
Insured patients mostly pay $0-50 a visit. Self-pay rates are not published, though the seller says they exist. Meto takes insurance for metabolic care and prescribes compounded semaglutide and compounded tirzepatide once a clinician has ordered lab work. By its own account, patients are matched inside minutes to board-certified specialists: metabolic health coaches, dietitians, obesity medicine physicians and endocrinologists. It also says it handles prior authorization, billing and insurance paperwork for Aetna, United Healthcare, Anthem and Blue Cross.
Read our full Meto review →Pros & Cons
Hims
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
- Names 4 pharmacies that fill its prescriptions, which most sellers do not
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- The FDA has issued Hims a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Meto
What we like
- The monthly price includes the medication, clinician visits, lab work and coaching
- We found no FDA warning letters issued to Meto
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
Hims wins this one, 6.8 to 4.1, above all for knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC. Meto fits better if bloodwork inside the monthly price rather than billed on top is your priority.
Choose Hims if…
You want knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC and an opening price near $199 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Strut Health
Semaglutide at $99/month, 48% below the typical price
From $99/mo
Get started →Enhance MD
Knowing which pharmacy fills the vial: it names Tru Meds Rx
From $169/mo
Get started →DudeMeds
Compounded semaglutide at $175/month
From $175/mo
Get started →Hims vs Meto: FAQ
Close alternatives to Hims and Meto
- Hims vs Hers
- Hims vs Care Bare Rx
- Hims vs Concierge MD LA
- Hims vs Corsica Health
- Meto vs Embody
- Meto vs TrimRx
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.